290 related articles for article (PubMed ID: 34108429)
1. Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.
Ayani N; Morimoto T; Sakuma M; Kikuchi T; Watanabe K; Narumoto J
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):397-402. PubMed ID: 34108429
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
[TBL] [Abstract][Full Text] [Related]
3. Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan.
Aoyama K; Tachi T; Kubo S; Koyama A; Watanabe M; Aoyama S; Noguchi Y; Tanaka K; Yasuda M; Shibata A; Mizui T; Teramachi H
Hum Psychopharmacol; 2024 May; 39(3):e2890. PubMed ID: 38180732
[TBL] [Abstract][Full Text] [Related]
4. The Additional Effect of Individualized Prescriber-Focused Feedback on General Guideline Instruction in Reducing Antipsychotic Polypharmacy in Inpatients.
Lochmann van Bennekom MWH; Gijsman HJ; Groenewoud H; Verkes RJ
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):129-134. PubMed ID: 33666400
[TBL] [Abstract][Full Text] [Related]
5. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
[TBL] [Abstract][Full Text] [Related]
6. Patterns of antipsychotics' prescription in Portuguese acute psychiatric wards: A cross-sectional study.
Campos Mendes J; Azeredo-Lopes S; Cardoso G
Psychiatry Res; 2016 Dec; 246():142-148. PubMed ID: 27693867
[TBL] [Abstract][Full Text] [Related]
7. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study.
Biancosino B; Barbui C; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2005 Nov; 20(6):305-9. PubMed ID: 16192838
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
9. Predictors of high-dose antipsychotic prescription in psychiatric patients in Hong Kong.
Hung GB; Cheung HK
Hong Kong Med J; 2008 Feb; 14(1):35-9. PubMed ID: 18239241
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Risk Factors for Antipsychotic Polypharmacy in Inpatient Psychiatry Units of a Community Hospital: A Retrospective Analysis.
Paudel S; Dahal R; Mathias J; Arjyal S; Markovic L
Community Ment Health J; 2019 Jul; 55(5):750-754. PubMed ID: 30805754
[TBL] [Abstract][Full Text] [Related]
11. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification.
Carmona-Huerta J; Castiello-de Obeso S; Ramírez-Palomino J; Duran-Gutiérrez R; Cardona-Muller D; Grover-Paez F; Fernández-Dorantes P; Medina-Dávalos R
BMC Psychiatry; 2019 Feb; 19(1):78. PubMed ID: 30791883
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study.
Sakuma M; Ida H; Nakamura T; Ohta Y; Yamamoto K; Seki S; Hiroi K; Kikuchi K; Nakayama K; Bates DW; Morimoto T
BMJ Qual Saf; 2014 Oct; 23(10):830-7. PubMed ID: 24742779
[TBL] [Abstract][Full Text] [Related]
14. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study.
Sakuma M; Bates DW; Morimoto T
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1221-6. PubMed ID: 22887972
[TBL] [Abstract][Full Text] [Related]
15. Effect of baseline renal and hepatic function on the incidence of adverse drug events: the Japan Adverse Drug Events study.
Takahashi Y; Sakuma M; Murayama H; Morimoto T
Drug Metab Pers Ther; 2018 Dec; 33(4):165-173. PubMed ID: 30414364
[TBL] [Abstract][Full Text] [Related]
16. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.
Kadra G; Stewart R; Shetty H; Jackson RG; Greenwood MA; Roberts A; Chang CK; MacCabe JH; Hayes RD
BMC Psychiatry; 2015 Jul; 15():166. PubMed ID: 26198696
[TBL] [Abstract][Full Text] [Related]
17. Audit of antipsychotic prescribing in a private psychiatric hospital.
Botvinik L; Ng C; Schweitzer I
Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
19. Conventional, atypical, and combination antipsychotic prescriptions: a 2-year comparison.
Tempier RP; Pawliuk NH
J Clin Psychiatry; 2003 Jun; 64(6):673-9. PubMed ID: 12823082
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals.
Ortiz G; Hollen V; Schacht L
J Psychiatr Pract; 2016 Jul; 22(4):283-97. PubMed ID: 27427840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
